Saponin adjuvant primes for a dominant interleukin-10 production to ovalbumin and to Trypanosoma cuuzi antigen

Immunology

Volumn 89, Issue 3, 1996, Pages 368-374

  Tadokoro, C E ^a   Macedo, M S ^a   Abrahamsohn, I A ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; FREUND ADJUVANT; GAMMA INTERFERON; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 10; INTERLEUKIN 4; PARASITE ANTIGEN; SAPONIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; FEMALE; IMMUNIZATION; LYMPH NODE CELL; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; T LYMPHOCYTE; TRYPANOSOMA CRUZI;

EID: 0029794876     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1996.d01-767.x     Document Type: Article

References (32)

1. DALSGAARD K. (1974) Saponin adjuvants. III. Isolation of a substance from Quillaja saponaria molina with adjuvant activity in foot-and-mouth disease vaccines. Arch Gesamte Virusforsch 44, 243.
2. BOMFORD R. & MCHARDY N. (1979) Corynebacterium parvum as an adjuvant for Trypanosoma cruzi epimastigote vaccines: a comparison with saponin and Bordetella pertussis. Parasitology 78, 77.
3. MCCOLM A.A., BOMFORD R. & DALTON L. (1982) A comparison of saponin with other adjuvants for the potentiation of protective immunity by a killed Plasmodium yoelli vaccines in the mouse. Parasit Immunol 4, 337.
4. KENSIL C.R., PATEL U., LENNICK M. & MARCIANI D. (1991) Separation and characterization of saponins with adjuvant activity from Quillaja saponaria molina cortex. J Immunol 146, 431.
5. BOMFORD R., STAPLETON M., WINSOR S., MCKNIGHT A. & ANDRONOVA T. (1992) The control of the antibody isotype response to recombinant human immunodeficiency virus gp 120 antigen by adjuvants. AIDS Res Human Retrovir 8, 1765.
6. VALENSI J.-P.M., CARLSON J.R. & VAN NEST G.A. (1994) Systemic cytokine profiles in BALB/c mice immunized with trivalent influenza vaccine containing MF59 oil emulsion and other advanced Adjuvants. J Immunol 153, 4029.
7. SCOTT M.T., BAHR G., MODDABER F., AFCHAIN D. & CHEDID L. (1984) Adjuvant requirements for protective immunization of mice using a Trypanosoma cruzi 90 K cell surface glycoprotein. Int Arch Allergy Appl Immunol 74, 373.
8. KENNEY J.S., HUGHES B.W., MASADA M.P. & ALLISON A.C. (1989) Influence of adjuvants on the quantity, affinity, isotype and epitope specificity of murine antibodies. J Immunol Methods 121, 157.
9. GRUN J.L. & MAURER P.H. (1989) Different T helper cell subsets elicited in mice utilizing two different adjuvant vehicles: the role of endogenous interleukin 1 in proliferative responses. Cell Immunol 121, 134.
10. FOX B.S. (1992) Antibody responses to a cytochrome c peptide do not correlate with lymphokine production patterns from helper T-cell subsets. Immunology 75, 164.
11. LAFAILLE M.A.C., OLIVEIRA L.C.B., LIMA G.C.A. & ABRAHAMSOHN I.A. (1990) Trypanosoma cruzi: maintenance of parasite-specific T cell responses in lymph nodes during the acute phase of the infection. Exp Parasitol 70, 164.
12. TITUS R.G. & CHILLER J.M. (1981) A simple and effective method to assess murine delayed type hypersensitivity to proteins. J Immunol Methods 45, 65.
13. MOSMANN T.R. (1994) Properties and functions of interleukin-10. Adv Immunol 56, 1.
14. + lymphocytes increase in vivo susceptibility to Trypanosoma cruzi infection. Cell Immunol 170, 41.
15. HSIEH C.S., HEIMBERGER A.B., GOLD J.S., O'GARRA A. & MURPHY K.M. (1992) Differential regulation of T helper phenotype development by interleukin 4 and 10 in an αβ T-cell-receptor transgenic system. Proc Natl Acad Sci USA 89, 6065.
16. MACATONIA S.T., DOHERTY T.M., KNIGHT S.C. & O'GARRA A. (1993) Differential effect of IL-10 on dendritic cell-induced T-cell proliferation and IFN-γ production. J Immunol 150, 3755.
17. POWRIE F., MENON S. & COFFMAN R.L. (1993) Inlerleukin-4 and interleukin-10 synergize to inhibit cell-mediated immunity in vivo. Eur J Immunol 23, 2223.
18. LI L., ELLIOT J.F. & MOSMANN T.R. (1994) IL-10 inhibits cytokine production, vascular leakage, and swelling during T helper 1 cell-induced delayed-type hypersensitivity. J Immunol 153, 3967.
19. MACHAL G., SEMAN M., MILON G., TRUFFA-BACHI P. & ZILBERFARB V. (1982) Local adoptive transfer of skin delayed-type hypersensitivity initiated by a single T lymphocyte. J Immunol 129, 954.
20. SILVA J.S., MORRISSEY P.J., GRABSTEIN K.H., MOHLER K.M., ANDERSON D. & REED S.G. (1992) Interleukin 10 and interferon γ regulation of experimental Trypanosoma cruzi infection. J Exp Med 175, 169.
21. GAZZINELLI R.T., OSWALD I.P., HIENY S., JAMES S.L. & SHER A. (1992) The microbicidal activity of interferon-γ-treated macrophages against Trypanosoma cruzi involves an L-arginine-dependent, nitrogen oxide-mediated mechanism inhibitable by interleukin-10 and transforming growth factor-β. Eur J Immunol 22, 2501.
22. ABRAHAMSOHN I.A., BLOTTA M.H.S.L. & Curotto M.A. (1981) Enhancement of delayed-type hypersensitivity to Trypanosoma cruzi in mice treated with Myconacterium bovis BCG and cyclophosphamide. Infect Immun 31, 1145.
23. BOMFORD R. (1982) Studies on the cellular site of action of the adjuvant activity of saponin for sheep erythrocytes. Int Arch Allergy Appl Immunol 67, 127.
24. BOMFORD R. (1980) Saponin and other haemolysins (vitamin A. aliphatic amines, polycne antibiotics) as adjuvants for SRBC in the mouse. Evidence for a role for cholesterol-binding in saponin adjuventicity. Int Arch Alergy Appl Immunol 63, 170.
25. XU-AMANO J., KIYONO H., JACKSON R.J. et al. (1993) Helper T cell subsets for immunoglobulin A responses: oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosa associated tissues, J Exp Med 178, 1309.
26. HORNQUIST K. & LYCKE N. (1993) Cholera toxin adjuvant greatly promotes antigen priming of T cells. Eur J Immunol 23, 2136.
27. + cytotoxic T lymphocyte-responses. J Immunol 148, 2357.
28. WU J.-Y., GARDNER B.H., MURPHY C.I. et al. (1992) Saponin adjuvant enhancement of antigen-specific immune responses to an experimental HIV-1 vaccine. J Immunol 148, 1519.
29. EMERY D.L., ROTHEL J.S. & WOOD P.R. (1990) Influence of antigens and adjuvants on the production of gamma-interferon and antibody by ovine lymphocytes. Immunol Cell Biol 68, 127.
30. VILLACRES-ERIKSSON M. (1995) Antigen presentation by naive macrophages, dendritic cells and B cells to primed T lymphocytes and their cytokine production following exposure to immunostaining complexes. Clin Exp Immunol 102, 46.
31. FLEBBE L.M. & BRALEY-MULLEN H. (1986) Immunopotentiating effects of the adjuvants SGP and Quil A. I. Antibody responses to T-dependent and T-independent antigens. Cell Immunol 99, 119.
32. DING, L. & STEVACH E.M. (1992) IL-10 inhibits mitogen-induced T cell proliferation by selectively inhibiting macrophage costimulatory function. J Immunol 148, 3133.